Concorde Medical Group — New York, New York

Concorde Medical Group is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Concorde Medical Group has participated in 23 clinical trials with 1 currently active.

Therapeutic areas: Colitis, Ulcerative, Crohn Disease, Hepatitis C, Chronic.

Sponsors: Celgene, Gilead Sciences, Enanta Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Concorde Medical Group?

Concorde Medical Group has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Concorde Medical Group conducted?

Concorde Medical Group has 23 clinical trials on record, with 1 currently active. Their work covers Colitis, Ulcerative, Crohn Disease, Hepatitis C, Chronic.

Is Concorde Medical Group accredited by Crixeo Health?

Yes — Concorde Medical Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Concorde Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.